BAM
AMED

Bellevue Asset Management’s Amedisys AMED Stock Holding History

Bellevue Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-280
Closed -$56K – 610
2020
Q2 		$56K Hold
280
– – 0.06% 149
2020
Q1 		$53K Hold
280
– – 0.06% 159
2019
Q4 		$47K Buy
+280
New +$41.6K 0.04% 159

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Asset Management's AMED Position: Q3 2020 in Review

Bellevue Asset Management sold out of Amedisys (AMED) in Q3 2020, closing a stake of 280 shares — an estimated $56K sold.

Bellevue Asset Management first reported a position in AMED in Q4 2019 and held it in 3 quarters. The position peaked at $56K in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Bellevue Asset Management reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
  • Bellevue Asset Management sold 280 Amedisys shares in Q3 2020, an estimated $56K.
  • Bellevue Asset Management first reported a position in Amedisys in Q4 2019 and held it in 3 quarters.
  • Bellevue Asset Management's Amedisys position peaked at $56K in Q2 2020.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Bellevue Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.